These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17458131)

  • 1. [Elucidation of anesthetic and analgesic effects of ketamine using NMDA receptor epsilon 1 subunit-deficient mice].
    Yamakura T; Petrenko AB; Baba Y; Sakimura K
    Masui; 2006 Nov; 55 Suppl():S141-4. PubMed ID: 17458131
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronopharmacological studies of ketamine in normal and NMDA epsilon1 receptor knockout mice.
    Sato Y; Kobayashi E; Hakamata Y; Kobahashi M; Wainai T; Murayama T; Mishina M; Seo N
    Br J Anaesth; 2004 Jun; 92(6):859-64. PubMed ID: 15064251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.
    Chizh BA
    J Psychopharmacol; 2007 May; 21(3):259-71. PubMed ID: 17591654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ketamine as an NMDA receptor antagonist].
    Kushikata T; Hirota K
    Masui; 2013 Jan; 62(1):38-43. PubMed ID: 23431892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of NMDA receptors in thiopental-induced loss of righting reflex, antinociception and anticonvulsion effects in mice.
    Ge ZJ; Zhang LC; Zeng YM; Da TJ; Wang JK; Cui GX; Tan YF; Zhao YP; Liu GJ
    Pharmacology; 2007; 80(2-3):127-33. PubMed ID: 17534122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vasodilatory effect of ketamine is independent of the N-methyl-D-aspartate receptor: lack of functional N-methyl-D-aspartate receptors in rat mesenteric artery smooth muscle.
    Noh HJ; Bae YM; Park SH; Kim JG; Kim B; Kim YS; Kim SH; Cho SI; Woo NS
    Eur J Anaesthesiol; 2009 Aug; 26(8):676-82. PubMed ID: 19352184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of central sensitization and pain by N-methyl-D-aspartate receptor antagonists.
    Pozzi A; Muir WW; Traverso F
    J Am Vet Med Assoc; 2006 Jan; 228(1):53-60. PubMed ID: 16426166
    [No Abstract]   [Full Text] [Related]  

  • 8. Ketamine: repurposing and redefining a multifaceted drug.
    Potter DE; Choudhury M
    Drug Discov Today; 2014 Dec; 19(12):1848-54. PubMed ID: 25224017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine, not fentanyl, suppresses pain-related magnetic fields associated with trigeminally innervated area following CO2 laser stimulation.
    Matsuura N; Shibukawa Y; Kato M; Ichinohe T; Suzuki T; Kaneko Y
    Neurosci Res; 2008 Oct; 62(2):105-11. PubMed ID: 18655812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of N-methyl-D-aspartate receptor epsilon1 subunit gene disruption of the action of general anesthetic drugs in mice.
    Sato Y; Kobayashi E; Murayama T; Mishina M; Seo N
    Anesthesiology; 2005 Mar; 102(3):557-61. PubMed ID: 15731593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine.
    Sinner B; Graf BM
    Handb Exp Pharmacol; 2008; (182):313-33. PubMed ID: 18175098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-methyl-D-aspartate (NMDA) antagonists--S(+)-ketamine, dextrorphan, and dextromethorphan--act as calcium antagonists on bovine cerebral arteries.
    Kamel IR; Wendling WW; Chen D; Wendling KS; Harakal C; Carlsson C
    J Neurosurg Anesthesiol; 2008 Oct; 20(4):241-8. PubMed ID: 18812887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic administration of ketamine for analgesia.
    Ben-Ari A; Lewis MC; Davidson E
    J Pain Palliat Care Pharmacother; 2007; 21(1):7-14. PubMed ID: 17430824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine: a controversial drug for neonates.
    Bhutta AT
    Semin Perinatol; 2007 Oct; 31(5):303-8. PubMed ID: 17905185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NMDA receptor antagonists on visceromotor reflexes and on intestinal motility, in vivo.
    Shafton AD; Bogeski G; Kitchener PD; Sanger GJ; Furness JB; Shimizu Y
    Neurogastroenterol Motil; 2007 Jul; 19(7):617-24. PubMed ID: 17539896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anesthetic-like modulation of a gamma-aminobutyric acid type A, strychnine-sensitive glycine, and N-methyl-d-aspartate receptors by coreleased neurotransmitters.
    Milutinovic PS; Yang L; Cantor RS; Eger EI; Sonner JM
    Anesth Analg; 2007 Aug; 105(2):386-92. PubMed ID: 17646495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the role of NMDA receptors in anesthesia: are we there yet?
    Petrenko AB; Yamakura T; Sakimura K; Baba H
    Eur J Pharmacol; 2014 Jan; 723():29-37. PubMed ID: 24333550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stereoselective effects of ketamine isomers on heteromeric N-methyl-D-aspartate receptor channels.
    Yamakura T; Sakimura K; Shimoji K
    Anesth Analg; 2000 Jul; 91(1):225-9. PubMed ID: 10866917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits.
    Fredriksson A; Pontén E; Gordh T; Eriksson P
    Anesthesiology; 2007 Sep; 107(3):427-36. PubMed ID: 17721245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A reviewing for abusing of ketamine].
    Yang J; Bian SZ
    Fa Yi Xue Za Zhi; 2007 Aug; 23(4):312-5. PubMed ID: 17896530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.